The use of iPSC technology for modeling Autism Spectrum Disorders

Autor(es)

Russo, Fabiele Baldino ^[1] ; Brito, Anita ^[1] ; de Freitas, Ariane Miranda ^[1] ; Castanha, Andrelissa ^[1] ; de Freitas, Beatriz C. ^[1] ; Baleeiro Beltrao-Braga, Patricia Cristina ^{[1, 2]}

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP - Brazil

^[2] Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP - Brazil

• Tipo de documento: Artigo de Revisão
• Fonte: Neurobiology of Disease; v. 130, OCT 2019.
• Citações Web of Science: 0

Resumo

Autism Spectrum Disorders (ASDs) are a group of neurodevelopmental disorders that influence social skills, involving communication, interaction, and behavior, usually with repetitive and restrictive manners. Due to the variety of genes involved in ASDs and several possible environmental factors influence, there is still no answer to what really causes syndromic and non-syndromic types of ASDs, usually affecting each individual in a unique way. However, we know that the mechanism underlying ASDs involves brain functioning. The human brain is a complex structure composed of close to 100 billion cells, which is a big challenge to study counting just with post mortem tissue investigation or genetic approaches. Therefore, human induced pluripotent stem cells (iPSC) technology has been used as a tool to produce viable cells for understanding a working brain. Taking advantage of patient-derived stem cells, researchers are now able to generate neurons, glial cells and brain organoids in vitro to model ASDs. In this review we report data from different studies showing how iPSCs have been a critical tool to study the different phenotypes of ASDs. (AU)

• Processo FAPESP: 11/20683-0 - Geração de células pluripotentes induzidas de pacientes com transtorno autista
• Beneficiário: Fabiele Baldino Russo
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 16/02978-6 - Modelagem celular de pacientes com Transtorno do Espectro do Autismo através de células-tronco pluripotentes induzidas (iPSC)
• Beneficiário: Fabiele Baldino Russo
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado